3,4-methylenedioxyamphetamine has been researched along with Cancer of Prostate in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hormonal treatment of advanced prostate cancer involves life disruptive side-effects, such as impotence, libido loss and bodily feminisation." | 1.32 | Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer. ( Morag, A; Navon, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrod, HL | 1 |
| Navon, L | 1 |
| Morag, A | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Cancer of Prostate
| Article | Year |
|---|---|
A piece of my mind. An essay on desire.
Topics: Attitude to Death; Attitude to Health; Erectile Dysfunction; Humans; Love; Male; Palliative Care; Pr | 2003 |
Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer.
Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Feminization; Gender Identity; Hormone Replaceme | 2004 |